Cysteine cathepsins and extracellular matrix degradation

被引:258
作者
Fonovic, Marko [1 ,2 ]
Turk, Boris [1 ,2 ,3 ]
机构
[1] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, SI-1000 Ljubljana, Slovenia
[2] Ctr Excellence Integrated Approaches Chem & Biol, SI-1000 Ljubljana, Slovenia
[3] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 61000, Slovenia
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2014年 / 1840卷 / 08期
关键词
Cathepsin; Extracellular matrix; Lysosome; Collagen; Osteoporosis; Glycosaminoglycan; ABDOMINAL AORTIC-ANEURYSMS; PH-INDUCED INACTIVATION; HUMAN PROCATHEPSIN B; PROTEASE ACTIVITY; CRYSTAL-STRUCTURE; K INHIBITOR; MOUSE MODEL; RHEUMATOID-ARTHRITIS; POSTMENOPAUSAL WOMEN; CANCER PROGRESSION;
D O I
10.1016/j.bbagen.2014.03.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Cysteine cathepsins are normally found in the lysosomes where they are involved in intracellular protein turnover. Their ability to degrade the components of the extracellular matrix in vitro was first reported more than 25 years ago. However, cathepsins were for a long time not considered to be among the major players in ECM degradation in vivo. During the last decade it has, however, become evident that abundant secretion of cysteine cathepsins into extracellular milieu is accompanying numerous physiological and disease conditions, enabling the cathepsins to degrade extracellular proteins. Scope of view: In this review we will focus on cysteine cathepsins and their extracellular functions linked with ECM degradation, including regulation of their activity, which is often enhanced by acidification of the extracellular microenvironment, such as found in the bone resorption lacunae or tumor microenvironment. We will further discuss the ECM substrates of cathepsins with a focus on collagen and elastin, including the importance of that for pathologies. Finally, we will overview the current status of cathepsin inhibitors in clinical development for treatment of ECM-linked diseases, in particular osteoporosis. Major conclusions: Cysteine cathepsins are among the major proteases involved in ECM remodeling, and their role is not limited to degradation only. Deregulation of their activity is linked with numerous ECM-linked diseases and they are now validated targets in a number of them. Cathepsins Sand K are the most attractive targets, especially cathepsin K as a major therapeutic target for osteoporosis with drugs targeting it in advanced clinical trials. General significance: Due to their major role in ECM remodeling cysteine cathepsins have emerged as an important group of therapeutic targets for a number of ECM-related diseases, including, osteoporosis, cancer and cardiovascular diseases. This article is part of a Special Issue entitled Matrix-mediated cell behaviour and properties. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:2560 / 2570
页数:11
相关论文
共 221 条
[71]   A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor [J].
Goulet, B ;
Baruch, A ;
Moon, NS ;
Poirier, M ;
Sansregret, LL ;
Erickson, A ;
Bogyo, M ;
Nepveu, A .
MOLECULAR CELL, 2004, 14 (02) :207-219
[72]   Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization [J].
Gowen, M ;
Lazner, F ;
Dodds, R ;
Kapadia, R ;
Feild, J ;
Tavaria, M ;
Bertoncello, I ;
Drake, F ;
Zavarselk, S ;
Tellis, I ;
Hertzog, P ;
Debouck, C ;
Kola, I .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (10) :1654-1663
[73]  
Grabowska UB, 2005, CURR OPIN DRUG DISC, V8, P619
[74]   Chemical approaches for functionally probing the proteome [J].
Greenbaum, D ;
Baruch, A ;
Hayrapetian, L ;
Darula, Z ;
Burlingame, A ;
Medzihradszky, KF ;
Bogyo, M .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (01) :60-68
[75]   Crystal structure of cathepsin X: a flip-flop of the ring of His23 allows carboxy-monopeptidase and carboxy-dipeptidase activity of the protease [J].
Guncar, G ;
Klemencic, I ;
Turk, B ;
Turk, V ;
Karaoglanovic-Carmona, A ;
Juliano, L ;
Turk, D .
STRUCTURE, 2000, 8 (03) :305-313
[76]  
Guncar G, 1998, STRUCTURE, V6, P51
[77]   Cleavage site specificity of cathepsin K toward cartilage proteoglycans and protease complex formation [J].
Hou, WS ;
Li, ZQ ;
Büttner, FH ;
Bartnik, E ;
Brömme, D .
BIOLOGICAL CHEMISTRY, 2003, 384 (06) :891-897
[78]   Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium [J].
Hou, WS ;
Li, WJ ;
Keyszer, G ;
Weber, E ;
Levy, R ;
Klein, MJ ;
Gravallese, EM ;
Goldring, SR ;
Brömme, D .
ARTHRITIS AND RHEUMATISM, 2002, 46 (03) :663-674
[79]   Cathepsin K is a critical protease in synovial fibroblast-mediated collagen degradation [J].
Hou, WS ;
Li, ZQ ;
Gordon, RE ;
Chan, K ;
Klein, MJ ;
Levy, R ;
Keysser, M ;
Keyszer, G ;
Brömme, D .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (06) :2167-2177
[80]   The lysosomal cysteine proteases in MHC class II antigen presentation [J].
Hsing, LC ;
Rudensky, AY .
IMMUNOLOGICAL REVIEWS, 2005, 207 :229-241